NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Metabolic dysfunction-associated steatotic liver disease, liver fibrosis and risk of cardiovascular disease: A prospective cohort study
Baek JW, Yang YS, Jung KJ, Kimm H, Kim SY, Lee S and Jee SH
In patients with NAFLD, liver fibrosis increases liver-related complications, but there is controversy about the increase in CVD. Based on a prospective cohort study, this study investigated the risk of cardiovascular disease due to liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).
The association between Naples Prognostic Score and all-cause and cardiovascular mortality in the general population with metabolic syndrome: A cohort study
Chen Z, Chen Z, Zhong Y and Wang Q
The Naples prognostic score (NPS) is a recognized inflammatory and nutritional scoring system used as a prognostic indicator in various cancers and, more recently, in non-cancer diseases. Its association with mortality in individuals with Metabolic Syndrome (MetS) is understudied. This study aims to investigate the link between NPS and both all-cause and cardiovascular disease (CVD) mortality in adults with MetS.
The Fibrosis-4 index predicts all-cause mortality in a cohort of patients at high cardiovascular risk partly through glomerular filtration rate reduction
Mirijello A, Pacilli G, Siena A, Mangiacotti A, D'Errico MM, Dilalla D, Lamacchia O, Fontana A, Copetti M, Piscitelli P, Targher G and De Cosmo SA
Fibrosis-4 (FIB-4) index is a widely used test for non-invasively assessing liver fibrosis. We aimed to investigate the association between FIB-4 index and risk of all-cause mortality in patients at high cardiovascular (CV) risk and to determine whether coexisting renal dysfunction mediates this association.
Milk and yogurt consumption and its association with cardiometabolic risk factors in patients with type 2 diabetes: The Fukuoka Diabetes Registry
Yoshinari M, Ohkuma T, Iwase M and Kitazono T
The effects of dairy products on cardiometabolic risk factors in patients with diabetes, especially in Asians, have yet to be fully investigated. Therefore, we aimed to characterise the relationship between milk and yogurt consumption and cardiometabolic risk factors in Japanese patients with diabetes.
Elevated concurrent carotid atherosclerosis rates in patients with metabolic dysfunction-associated fatty liver disease (MAFLD) compared to non-alcoholic fatty liver disease (NAFLD): A cross-sectional observational study
Chung NT, Hsu CY, Shih NC and Wu JJ
Non-alcoholic fatty liver disease (NAFLD) has been recognized as an independent risk factor for atherosclerotic cardiovascular disease. Recently, there has been a shift towards diagnosing metabolic dysfunction-associated fatty liver disease (MAFLD), offering simplified criteria and improved risk assessment. However, the association between MAFLD and carotid atherosclerosis remains poorly understood.
Development of a CVD mortality risk score using nutritional predictors: A risk prediction model in the Golestan Cohort Study
Jabbari M, Barati M, Kalhori A, Eini-Zinab H, Zayeri F, Poustchi H, Pourshams A, Hekmatdoost A and Malekzadeh R
We aimed to develop a dietary score using prediction model method for evaluating the risk of cardiovascular disease (CVD) mortality and suggesting a simple and practical scoring system within the healthcare context.
The impact of iron deficiency on prognosis in stroke and non-stroke populations: A retrospective cohort study
Wang Q, Han W, Wang T, Deng H and Zhong J
Iron deficiency (ID) leads to a significant global health burden, but research on the impact of ID on the prognosis of stroke patients is rare. We aim to investigate the impact of ID on the all-cause mortality of both the stroke and non-stroke individuals.
Comment on "Linear associations of Chinese visceral adiposity index and its change with hyperuricemia: A prospective cohort study"
Zhao H, Xu J and Zhou Y
The triglyceride-glucose index: A valuable tool for uncovering the hidden connection between metabolic diseases and arterial ageing
Pucci G, Alcidi R and Curcio R
Circulating β-hydroxybutyrate levels are associated with major adverse clinical events in patients with acute myocardial infarction
Dai Y, Xie L, Zhang Y, He Y, Liu H, Kong S, Chen W, Li H, Zhan Y, Tan N, Duan C, He P, Liu Y and Xue L
Acute myocardial infarction is associated with high mortality, and effective biomarkers are required for the risk stratification. In cardiovascular diseases, circulating levels of ketone bodies (KB) such as β-hydroxybutyrate (β-OHB) and acetoacetate are altered. However, the relationship between circulating KB levels and major adverse clinical events (MACE) in patients with ST-elevation myocardial infarction (STEMI) is unknown.
Consumption of plant sterols-enriched soy milk with a healthy dietary pattern diet lowers blood pressure in adults with metabolic syndrome: A randomized controlled trial
Xu Y, Sutanto CN, Xia X, Toh DWK, Gan AX, Deng Q, Ling LH, Khoo CM, Foo RS and Kim JE
Plant sterols (PS) have been shown to lower blood lipid-lipoproteins concentrations and may serve as a potential functional ingredient for cardiovascular disease (CVD) risk management. However, there are limited studies examining this effect in individuals with metabolic syndrome (MetS). The aim of this study was to evaluate the effects of PS-enriched food consumption as part of a healthy dietary pattern (HDP) on blood pressure and endothelial function in Singaporean adults with MetS.
Reply to Kawada: The meta-analysis of nut intake and prostate cancer risk
Balali A, Askari G, Anjom-Shoae J and Sadeghi O
Comparison between Friedewald's and Sampson's formulas in the estimation of high levels of measured LDL-cholesterol in youth with obesity
Di Bonito P, Corica D, Wasniewska MG, Di Sessa A, Miraglia Del Giudice E, Licenziati MR, Improda N and Valerio G
To assess the performance of Friedewald's and Sampson's formulas in relation to high or borderline-high levels of measured LDL-Cholesterol (LDL-C) in youths with overweight/obesity (OW/OB).
Effects of calorie restriction therapy on health-related outcomes in patients with heart failure, a systematic review and meta-analysis
Cheng M, Zhu C, Liu H, Pu C and Hou Y
We conducted this systematic review to comprehensively assess the impact of CRT on health-related outcomes among patients with HF.
Association between cardiovascular risk factors and dilated and hypertrophic cardiomyopathy: Mendelian randomization analysis
Zou C, Zou H, Jiang Y, Lai S and Liu J
Dilated cardiomyopathy is a major cause of heart failure, and hypertrophic cardiomyopathy is a common cause of sudden cardiac death in young adults. Epidemiological studies reporting the association between these cardiomyopathies and common cardiovascular risk factors, including smoking, alcohol, and obesity, are limited, and the published studies are mostly observational, making them vulnerable to bias.
Visceral adiposity: A major mediator of the relationship between epicardial adiposity and cardiorespiratory fitness in adults
Chartrand DJ, Larose E, Poirier P, Mathieu P, Alméras N, Pibarot P, Lamarche B, Rhéaume C, Lemieux I, Després JP and Piché ME
Epicardial adiposity has been positively associated with visceral adipose tissue (VAT). Few studies have examined the association between cardiorespiratory fitness (CRF) and epicardial adiposity. Furthermore, whether this relationship was independent of VAT remains unexplored. Our purpose was to investigate the contribution of VAT in the relationships between CRF, physical activity (PA) and epicardial adipose tissue (EAT) in asymptomatic women and men.
Adverse event reporting of combining SGLT2 inhibitor and GLP1 receptor agonist: A real-world study from FAERS
Tian C, Yang Z, Zhao S, Zhang P and Li R
We evaluate whether the combination of sodium-glucose cotransporter-2 inhibitor(SGLT2i) and glucagon-like peptide-1 receptor agonist(GLP1RA) disproportionally increases the reporting of adverse events compared with SGLT2i or GLP1RA monotherapy in the FDA adverse event reporting system (FAERS).
Optimizing the lifestyle of patients with type 2 diabetes mellitus - Systematic review on the effects of combined diet-and-exercise interventions
Amerkamp J, Benli S, Isenmann E and Brinkmann C
To investigate the effects of combined diet-and-exercise interventions in patients with type 2 diabetes mellitus (T2DM).
Systemic inflammation markers and the prevalence of hypertension in 8- to 17-year-old children and adolescents: A NHANES cross-sectional study
Zhang W, Wang Q, Liu H, Hong F, Tang Q, Hu C, Xu T, Lu H, Ye L, Zhu Y and Song L
The recent emphasis on systemic inflammation markers has focused primarily on their association with cardiac disorders, particularly the prevalence of hypertension, in adults but not children and adolescents. This research aimed to explore the associations between systemic inflammation markers and the occurrence of hypertension in 8- to 17-year-old children and adolescents in the United States.
Trans-fat labelling and potential presence of industrially produced trans-fat in the New Zealand packaged food supply: 2015-2019 & 2022
Zhang J, Bradbury KE, Young L and Gontijo de Castro T
The World Health Organization (WHO) recommends that countries reduce industrially produced TFA (iTFA) in the food supply. However, New Zealand (NZ) has no mandatory regulation to control amounts of iTFA in foods. The objectives of this study were to assess within the NZ packaged food supply in recent years (2015-19 and 2022): i) the availability of products displaying information on TFA content on nutrition information panels (NIPs), ii) the content of TFA declared, and iii) the presence/potential presence of iTFA (n = 85,892 products).
Trends and disability-attributable risk factors of type 2 diabetes mellitus in Southeast Asia (1990-2019): An in-depth 30-year analysis from the Global Burden of Disease study
Nugrahani ASD, Muharram FR, Novida H, Swannjo JB, Wibisono S and Wungu CDK
To provide insight on targeted approach to mitigate diabetes burden, this research aims to analyze the trends of prevalence, mortality, and disability attributable to risk factors for type 2 diabetes mellitus (T2DM) from 1990 to 2019 in the Southeast Asia (SEA) region.